NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

Dr. William Feldman is a physician and researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. W.B. Feldman and Others. The Future of Drug-Pricing Transparency. N Engl J Med 2021;384:489-491.

More from New England Journal of Medicine Interviews

  1. 11:56NEJM Interview: Dr. Andrew Ryan on new legislation to prevent patients from receiving large and unexpected medical bills.Apr 14, 2021
  2. 24:11Vaccine Successes and Vaccine Adverse EventsApr 14, 2021
  3. 12:14NEJM Interview: Dr. Ingrid Katz on promotion and acceleration of global access to Covid-19 vaccines.Apr 07, 2021
  4. 19:14Antibody Responses to Natural Infection and VaccinationApr 07, 2021
  5. 09:26NEJM Interview: Dr. Christopher Elias on progress in containing infectious diseases and steps for preventing and countering new threats.Mar 31, 2021
  6. 35:18Delivering Covid-19 Vaccines to Minority CommunitiesMar 31, 2021
  7. 07:02NEJM Interview: Dr. Paul Offit on how more than two centuries of vaccine advances have paved the way for Covid-19 vaccines.Mar 24, 2021
  8. 37:00What Earlier Epidemics Teach Us about Covid-19Mar 24, 2021
  9. 08:03NEJM Interview: Dr. Jane Zhu on the growth of private-equity investment in medical practices.Mar 17, 2021
  10. 19:24Efficacy of Current Covid-19 Vaccines against Variant VirusesMar 17, 2021